246710 Stock Chart & Stats
₩2340.00
₩10.00(0.43%)
―
--
Day’s Range― - ―
52-Week Range₩1,127.00 - ₩4,925.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)230.03K
Market Cap
₩111.53B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding47,664,505
10 Day Avg. Volume221,195
30 Day Avg. Volume230,033
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
246710 FAQ
What was T&R Biofab Co., Ltd’s price range in the past 12 months?
T&R Biofab Co., Ltd lowest stock price was ₩1127.00 and its highest was ₩4925.00 in the past 12 months.
What is T&R Biofab Co., Ltd’s market cap?
T&R Biofab Co., Ltd’s market cap is ₩111.53B.
When is T&R Biofab Co., Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were T&R Biofab Co., Ltd’s earnings last quarter?
Currently, no data Available
Is T&R Biofab Co., Ltd overvalued?
According to Wall Street analysts T&R Biofab Co., Ltd’s price is currently Undervalued.
Does T&R Biofab Co., Ltd pay dividends?
T&R Biofab Co., Ltd does not currently pay dividends.
What is T&R Biofab Co., Ltd’s EPS estimate?
T&R Biofab Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does T&R Biofab Co., Ltd have?
T&R Biofab Co., Ltd has 47,664,505 shares outstanding.
What happened to T&R Biofab Co., Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of T&R Biofab Co., Ltd?
Currently, no hedge funds are holding shares in KR:246710
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cell Biotech Co., Ltd
―
Genexine, Inc.
―
L&K BIOMED Co., Ltd.
―
CORESTEMCHEMON Inc.
―
ViGenCell, Inc.
―